United Therapeutics Corporation
UTHR | NASDAQ
$493.10
-$1.53 (-0.31%)
At close: Sep 21, 2026, 4:00 PM ET
$492.77
-$0.33 (-0.07%)
Pre-market:
Sep 22, 2026, 5:41 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.15B | 3.17B | 3.18B | 3.13B | 3.08B | 2.99B | 2.88B | 2.76B | 2.62B | 2.5B | 2.33B | 2.2B | 2.11B | 1.98B | 1.94B | 1.86B | 1.79B | 1.77B | 1.69B | 1.66B | 1.59B | 1.51B |
Cost of Revenue | 437.2M | 425.3M | 384.4M | 356.9M | 339.1M | 329.3M | 309.7M | 304.8M | 291.8M | 278.1M | 257.5M | 242.4M | 209.5M | 175.1M | 148.7M | 127.4M | 117.9M | 125.4M | 122.5M | 122.7M | 119M | 107.7M |
Gross Profit | 2.72B | 2.74B | 2.8B | 2.77B | 2.74B | 2.66B | 2.57B | 2.45B | 2.32B | 2.22B | 2.07B | 1.96B | 1.9B | 1.81B | 1.79B | 1.73B | 1.67B | 1.64B | 1.56B | 1.53B | 1.47B | 1.4B |
Operating Income | 1.4B | 1.44B | 1.49B | 1.49B | 1.45B | 1.4B | 1.38B | 1.28B | 1.26B | 1.26B | 1.18B | 1.1B | 1.09B | 976.1M | 979.7M | 973.9M | 888.3M | 908.7M | 555.9M | 451.4M | 443.8M | 362.1M |
Interest Income | 162.9M | 182.7M | 192M | 198.1M | 201.5M | 196.4M | 199.1M | 200.8M | 196.3M | 187.3M | 162.7M | 132.5M | 100.5M | 70.1M | 45.2M | 28.6M | 19.1M | 16.3M | 16.7M | 17.5M | 20.1M | 23.3M |
Pretax Income | 1.57B | 1.61B | 1.71B | 1.67B | 1.62B | 1.56B | 1.54B | 1.44B | 1.4B | 1.38B | 1.27B | 1.16B | 1.12B | 933.8M | 950.6M | 912.3M | 804.2M | 870.1M | 593.9M | 567.8M | 582.4M | 499.8M |
Net Income | 1.31B | 1.29B | 1.33B | 1.27B | 1.24B | 1.21B | 1.2B | 1.11B | 1.07B | 1.05B | 984.8M | 899.8M | 871.5M | 728.3M | 727.3M | 707.4M | 630.8M | 687.4M | 475.8M | 462.4M | 470.9M | 405.4M |
Selling & General & Admin | 730.9M | 746.5M | 732.5M | 705.2M | 742.6M | 729.4M | 703.7M | 673.4M | 581.8M | 534.2M | 477.1M | 511M | 481.8M | 493.3M | 485M | 446.8M | 457.5M | 428.8M | 467M | 497.8M | 455M | 448.1M |
Research & Development | 551.5M | 539.2M | 550M | 544.3M | 520.3M | 525.9M | 481M | 498.6M | 479.8M | 429.2M | 408M | 350.5M | 331.9M | 336.8M | 322.9M | 311.9M | 325M | 305.4M | 540.1M | 583.3M | 572.8M | 588.2M |
Other Expenses | 31.5M | 21.7M | 21.7M | 27.7M | 27.7M | 6M | 6M | n/a | n/a | -600K | -600K | -600K | -600K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100K | -100K |
Operating Expenses | 1.31B | 1.31B | 1.3B | 1.28B | 1.29B | 1.26B | 1.19B | 1.17B | 1.06B | 963.4M | 885.1M | 861.5M | 813.7M | 830.1M | 807.9M | 758.7M | 782.5M | 734.2M | 1.01B | 1.08B | 1.03B | 1.04B |
Interest Expense | 12M | 16.4M | 19.5M | 24.3M | 31.4M | 35.7M | 42.9M | 50.1M | 55.6M | 58.8M | 59.3M | 56.5M | 50.1M | 41.5M | 32.4M | 24.8M | 20.2M | 18.7M | 18.6M | 18.7M | 19M | 19.9M |
Selling & Marketing Expenses | 127M | 120.7M | 118.6M | 112.9M | 105.3M | 99.7M | 96.3M | 93.4M | 93.4M | 88.1M | 81.8M | 80.7M | 77.2M | 73.2M | 70.8M | 64.2M | 64.2M | 65.2M | 64.4M | 64.8M | 60M | 55.6M |
Cost & Expenses | 1.75B | 1.73B | 1.69B | 1.63B | 1.63B | 1.59B | 1.5B | 1.48B | 1.35B | 1.24B | 1.14B | 1.1B | 1.02B | 1.01B | 956.6M | 886.1M | 900.4M | 859.6M | 1.13B | 1.2B | 1.15B | 1.14B |
Income Tax Expense | 262.1M | 321.3M | 379.2M | 394.7M | 374.9M | 353.2M | 343.9M | 327M | 331.7M | 330.5M | 289.5M | 257.9M | 246.9M | 205.5M | 223.3M | 204.9M | 173.4M | 182.7M | 118.1M | 105.4M | 111.5M | 94.4M |
Shares Outstanding (Basic) | 42.6M | 43.5M | 44.3M | 43.8M | 45.1M | 44.9M | 45.2M | 44.6M | 44.4M | 47M | 47M | 46.9M | 46.9M | 46.3M | 45.8M | 48.7M | 48.1M | 47.69M | 45.1M | 44.9M | 44.8M | 44.6M |
Shares Outstanding (Diluted) | 45.8M | 47.2M | 47.9M | 47.3M | 48.3M | 48.6M | 48.7M | 48.4M | 47.5M | 49.7M | 49.8M | 49.7M | 49.5M | 49.6M | 49.4M | 48.7M | 48.1M | 47.7M | 47.8M | 47.6M | 47.3M | 46.4M |
EPS (Basic) | 30.23 | 29.27 | 30.13 | 28.51 | 27.71 | 27.11 | 26.45 | 24.33 | 23.11 | 22.38 | 21.06 | 19.32 | 18.52 | 15.40 | 15.23 | 14.84 | 13.55 | 14.99 | 10.59 | 10.32 | 10.56 | 9.14 |
EPS (Diluted) | 27.91 | 27.05 | 27.86 | 26.39 | 25.62 | 25.06 | 24.60 | 22.77 | 21.76 | 21.15 | 19.84 | 18.15 | 17.68 | 14.85 | 15.02 | 14.70 | 13.21 | 14.45 | 10.03 | 9.87 | 10.29 | 9.05 |
EBITDA | 1.65B | 1.71B | 1.81B | 1.76B | 1.72B | 1.66B | 1.65B | 1.55B | 1.52B | 1.49B | 1.39B | 1.26B | 1.21B | 1.02B | 1.03B | 1.01B | 898.6M | 962.7M | 686.4M | 584.1M | 595.6M | 514.1M |
EBIT | 1.59B | 1.63B | 1.72B | 1.68B | 1.64B | 1.59B | 1.58B | 1.49B | 1.46B | 1.44B | 1.33B | 1.21B | 1.16B | 969.1M | 976.8M | 961.1M | 848.4M | 912.8M | 636.5M | 533.7M | 545.8M | 464.1M |
Depreciation & Amortization | 67.3M | 88.4M | 85.6M | 82.5M | 79.7M | 77.3M | 72.5M | 66.5M | 60.7M | 54.9M | 53.2M | 52.7M | 52.3M | 52.1M | 51.3M | 50.7M | 50.2M | 49.9M | 49.9M | 50.4M | 49.8M | 50M |
Add to Watchlist
Select watchlists to add or remove UTHR